Get the Stockscreener App
3.55
1.39%
-0.05
After Hours:
3.54
-0.010
-0.28%
Clover Health Investments Corp stock is traded at $3.55, with a volume of 4.73M.
It is down -1.39% in the last 24 hours and up +42.00% over the past month.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
See More
Previous Close:
$3.60
Open:
$3.59
24h Volume:
4.73M
Relative Volume:
0.77
Market Cap:
$1.87B
Revenue:
$1.92B
Net Income/Loss:
$-85.55M
P/E Ratio:
-21.35
EPS:
-0.1663
Net Cash Flow:
$-68.98M
1W Performance:
+2.31%
1M Performance:
+42.00%
6M Performance:
+55.70%
1Y Performance:
+8.23%
1-Day Range:
$3.54
$3.695
1-Week Range:
$3.2834
$3.695
52-Week Range:
$1.58
$3.92
Clover Health Investments Corp Stock (CLOV) Company Profile
Name
Clover Health Investments Corp
Sector
Industry
Phone
(201) 432-2133
Address
30 MONTGOMERY STREET, JERSEY CITY
Compare CLOV vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLOV
Clover Health Investments Corp
|
3.55 | 1.90B | 1.92B | -85.55M | -68.98M | -0.1663 |
UNH
Unitedhealth Group Inc
|
388.47 | 347.35B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
93.26 | 119.07B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
394.69 | 84.65B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
286.24 | 74.60B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
307.95 | 36.46B | 137.20B | 1.15B | 1.27B | 9.3439 |
Clover Health Investments Corp Stock (CLOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-17-24 | Initiated | Craig Hallum | Buy |
| Oct-07-24 | Initiated | UBS | Neutral |
| Feb-02-22 | Initiated | Canaccord Genuity | Buy |
| Feb-02-22 | Upgrade | Cowen | Underperform → Market Perform |
| Jan-19-22 | Initiated | SVB Leerink | Mkt Perform |
| Jan-10-22 | Resumed | Citigroup | Neutral |
| Jan-07-22 | Downgrade | Credit Suisse | Neutral → Underperform |
| Sep-10-21 | Initiated | Cowen | Underperform |
| Sep-02-21 | Resumed | Citigroup | Neutral |
| Jul-12-21 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| May-17-21 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Feb-02-21 | Initiated | Citigroup | Buy |
| Feb-01-21 | Initiated | JP Morgan | Neutral |
View All
Clover Health Investments Corp Stock (CLOV) Latest News
PNC Financial Services Group Inc. Sells 699,960 Shares of Clover Health Investments, Corp. $CLOV - MarketBeat
Clover Health Earnings Call Signals Profitable Growth - TipRanks
A Look At Clover Health (CLOV) Valuation After First Positive GAAP Net Income And Q1 2026 Turnaround Progress - simplywall.st
Clover Health’s Bullish Setup Still Looks Compelling (NASDAQ:CLOV) - Seeking Alpha
Clover Health director Carladenise Edwards sells $229,687 in stock - Investing.com UK
Insider Sell: Carladenise Edwards Sells Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health director Carladenise Edwards sells $229,687 in stock By Investing.com - Investing.com UK
Director at Clover Health (NASDAQ: CLOV) sells 67K shares at ~$3.42 - Stock Titan
RSU vesting leads Clover Health (CLOV) interim CFO to tax share withholding - Stock Titan
Rule 144 notice: Morgan Stanley Smith Barney lists CLOV share lots (CLOV) - Stock Titan
Clover Health Q1 2026: Margin Expansion, AI-Driven Care, and Strategic Growth Outlook - Minichart
Clover Health Highlights Q1 Outlook and Profitability Path - TipRanks
Clover publishes Q1 2026 supplemental Q&A on Clover Assistant, enrollment and guidance - TradingView
Clover Health (Nasdaq: CLOV) details 2026 outlook and tech strategy in Q&A - Stock Titan
Clover Health shares jump on 53% surge in Medicare Advantage membership - MSN
Clover Health Inv stock (US18914F1030): Short interest shifts after strong Q1 revenue jump - AD HOC NEWS
The Top 5 Analyst Questions From Clover Health’s Q1 Earnings Call - Yahoo Finance
CLOV Technical Analysis & Stock Price Forecast - Intellectia AI
symbol__ Stock Quote Price and Forecast - CNN
Q1 2026 Clover Health Investments Corp Earnings Call Transcript - GuruFocus
Clover Health Investments Corp (HAM:7QD) Stock Earnings Transcripts - GuruFocus
[144] CLOVER HEALTH INVESTMENTS, CORP. /DE SEC Filing - Stock Titan
CLOV Q3 Earnings Miss, Stock Falls on Raised Insurance BER View - MSN
Insider Sell: Brady Priest Sells 98,039 Shares of Clover Health Investments Corp (CLOV) - GuruFocus
Clover Health Inv stock (US18914F1030): Recent Medicare Advantage enrollment gains - AD HOC NEWS
Clover Health CEO Brady Priest sells $345,097 in shares By Investing.com - Investing.com Nigeria
[Form 4] CLOVER HEALTH INVESTMENTS, CORP. /DE Insider Trading Activity - Stock Titan
Clover Health CEO Brady Priest sells $345,097 in shares - Investing.com
Brady Priest sells 175,000 CLOV shares (CLOV) reported on Form 144 - Stock Titan
Clover Health (CLOV) Is Up 25.7% After Q1 Return To Profitability And Revenue Surge – Has The Bull Case Changed? - simplywall.st
Life Insurance In Force of Clover Health Investments, Corp. – NASDAQ:CLOV - TradingView
Clover Health Investments And 2 Other Insider Picks For Growth - Yahoo Finance
MSN Money - MSN
A Look At Clover Health (CLOV) Valuation After Profitability Return And Medicare Advantage Growth - Yahoo Finance
Clover Health Investments 1Q 2026: Revenue $749.19M, EPS $0.05— 10-Q Summary - TradingView
Clover Health (NASDAQ: CLOV) turns Q1 2026 profit as Medicare Advantage revenue surges - Stock Titan
MSN - MSN
Why Clover Health (CLOV) Stock Is Up Today - Barchart.com
Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises - Zacks Investment Research
Clover Health Investments, Corp. Q1 2026 Earnings Call Summary - Yahoo Finance
May 2026's Standout Penny Stocks To Watch - simplywall.st
Clover Health Q1 2026 slides: revenue surges 62%, profitability returns By Investing.com - Investing.com Canada
Clover Health Investments, Corp. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:CLOV) 2026-05-07 - Seeking Alpha
EDGAR Filing Documents for 0001801170-26-000102 - SEC.gov
Clover Health Investments (NASDAQ:CLOV) Releases Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Clover Health Investments, Corp. (CLOV) meets Q1 earnings estimates - MSN
Clover Health Investments Q1 Earnings Call Highlights - MarketBeat
Clover Health Q1 2026 slides: revenue surges 62%, profitability returns - Investing.com
CLOV: Q1 2026 delivered 51% membership growth, $27M net income, and 62% revenue growth year-over-year - TradingView
Earnings call transcript: Clover Health Q1 2026 sees revenue beat, EPS miss By Investing.com - Investing.com South Africa
Earnings call transcript: Clover Health Q1 2026 sees revenue beat, EPS miss - Investing.com Australia
Clover Health Investments Corp Stock (CLOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):